Why Medication Cost Matters for Adherence

You've determined that Esterified Estrogens/Methyltestosterone is the right therapy for your patient's menopausal symptoms. But if she can't afford it, the prescription might as well be blank paper. Medication cost is one of the most common — and most preventable — barriers to adherence in hormone therapy. Studies consistently show that out-of-pocket costs directly affect whether patients fill their prescriptions, and menopause treatments are no exception.

This guide gives you practical tools to help your patients access Esterified Estrogens/Methyltestosterone at a price they can manage, from discount cards and generic strategies to patient assistance programs and cost-conscious prescribing.

What Your Patients Are Paying

Here's the current pricing landscape for Esterified Estrogens/Methyltestosterone (EEMT) in 2026:

• Average retail price (cash, no insurance): $140 to $150 for a 30-day supply (generic)
• Per 100 tablets (0.625 mg/1.25 mg): Approximately $259 at retail
• With discount coupons: As low as $34 to $39 (GoodRx)
• Insurance copay: Varies widely — typically Tier 2 or Tier 3 on formularies ($20 to $75 depending on the plan)

The brand names (Estratest, Covaryx) have been largely discontinued. Generic EEMT is the standard, which helps keep costs lower — but $140 per month cash price is still a significant burden for many patients, especially those on fixed incomes or in Medicare donut holes.

Manufacturer Savings Programs

Unlike many brand-name medications, there are no active manufacturer savings or copay card programs for Esterified Estrogens/Methyltestosterone as of 2026. The original brand manufacturers (Solvay, which made Estratest, and others) have largely exited the market, and generic manufacturers typically do not offer patient savings programs.

This means other savings strategies become especially important for your patients.

Coupon and Discount Cards

Free prescription discount cards are the single most impactful tool for uninsured or underinsured patients. These can reduce the cash price by 70% or more:

• GoodRx: Prices as low as $34 to $39 for a 30-day supply. Patients can print or show the coupon on their phone at the pharmacy. No registration required.
• SingleCare: Up to 80% off retail pricing. Accepted at most major pharmacy chains.
• RxSaver: Comparison pricing across pharmacies with printable coupons.
• Optum Perks: Discount pricing available at participating pharmacies.
• BuzzRx: Free coupon card with savings at chain and independent pharmacies.
• America's Pharmacy: Additional discount option for generic medications.

Clinical pearl: Patients often don't know these exist, or they assume discount cards can't be used with insurance. In many cases, the coupon price beats the insurance copay — especially for patients with high-deductible plans or who are in the Medicare Part D coverage gap. Encourage your patients to compare both prices at the pharmacy counter.

For a patient-facing guide you can share, see our savings guide for patients.

Patient Assistance Programs

For patients with financial hardship — particularly those who are uninsured, underinsured, or on low fixed incomes — the following resources can help:

• NeedyMeds (needymeds.org): Comprehensive database of assistance programs, including those covering generic medications. Patients can search by drug name and find eligibility criteria.
• RxAssist (rxassist.org): Directory of patient assistance programs maintained by healthcare professionals. A good starting point for identifying options.
• State Pharmaceutical Assistance Programs (SPAPs): Many states offer programs that help residents pay for prescriptions. Eligibility and benefits vary by state. The Medicare website maintains a list of SPAPs at medicare.gov.
• Medicaid: For patients who qualify based on income, Medicaid typically covers this medication with minimal or no copay.
• Extra Help (Low-Income Subsidy): Medicare patients with limited income and resources may qualify for Extra Help, which significantly reduces Part D costs. Patients can apply at ssa.gov or their local Social Security office.

Tip for your workflow: Consider designating a staff member or medical assistant to help patients navigate these programs. Even a brief conversation at checkout — "Do you need help affording this medication?" — can open the door to resources patients didn't know about.

Generic Alternatives and Therapeutic Substitution

Esterified Estrogens/Methyltestosterone is already available as a generic (EEMT), so there's no brand-to-generic switch available. However, there are therapeutic alternatives worth considering if cost is a primary barrier:

Estrogen-Only Therapies (Lower Cost)

• Conjugated Estrogens (Premarin generic): If the patient's vasomotor symptoms might respond to estrogen alone at a higher dose or with an adjusted formulation, this is often less expensive and more widely available.
• Estradiol (oral or transdermal): Generic Estradiol tablets can cost as little as $10 to $20 per month. Transdermal patches (generic Estradiol patches) are also affordable and may carry lower cardiovascular risk.

Adding Testosterone Separately

• If the testosterone component is essential for the patient's symptom management (e.g., persistent low libido or fatigue), consider prescribing generic Estradiol plus compounded testosterone cream. While compounded testosterone is not FDA-approved for women, it's commonly prescribed off-label. The combined cost may still be lower than EEMT depending on the compounding pharmacy.

Combination Alternatives

• Prempro (Conjugated Estrogens/Medroxyprogesterone): Not equivalent (progestin instead of androgen), but may be appropriate for patients who need uterine protection and whose hot flashes respond to estrogen-progestin therapy.
• Bijuva (Estradiol/Progesterone): Bioidentical combination. May have manufacturer savings programs that EEMT lacks.

For a complete comparison, see our clinical guide on alternatives to Esterified Estrogens/Methyltestosterone.

Building Cost Conversations Into Your Workflow

Cost shouldn't be an afterthought — it's a clinical variable that directly impacts outcomes. Here are practical ways to integrate cost awareness into your prescribing:

At the Point of Prescribing

• Ask about cost concerns upfront: "Before I send this prescription, do you have any concerns about the cost?" Many patients won't volunteer this information unless asked.
• Check formulary status: Use your EHR's formulary checker or ask the patient's insurance plan whether EEMT is covered, and at what tier. If prior authorization or step therapy is required, initiate it proactively — don't let the patient discover the barrier at the pharmacy counter.
• Mention discount cards: A simple "If your copay is more than $40, check GoodRx — it might be cheaper" takes 10 seconds and can save your patient $100 per month.

At Follow-Up Visits

• Ask about fill rates: "Have you been able to fill and take this medication as prescribed?" Non-adherence due to cost often presents as missed doses or skipped refills.
• Reassess cost-benefit: If the patient is struggling financially, consider whether the clinical benefit justifies the cost, or if a therapeutic switch might achieve similar outcomes at lower cost.

In Your Practice

• Create a cost resources handout: A simple one-page sheet listing discount card websites, patient assistance programs, and your practice's process for helping with prior authorizations.
• Use Medfinder for Providers to help patients locate pharmacies that stock this medication at competitive prices.
• Designate a point person: Having one staff member familiar with discount programs and prior authorization processes can dramatically improve patient access and reduce phone calls back to your office.

Insurance and Prior Authorization Tips

Some practical notes on navigating insurance for Esterified Estrogens/Methyltestosterone:

• Step therapy: Many plans require patients to try estrogen-alone therapy before approving this combination. Document the trial and inadequate response clearly in the chart — it speeds up the prior authorization process.
• Prior authorization: If required, submit with documentation of the patient's symptom severity, prior treatment failures, and clinical rationale for the estrogen-androgen combination. Include the limited manufacturer landscape as additional context if relevant.
• Appeals: If initially denied, appeal with additional clinical documentation. Peer-to-peer reviews can be effective for this medication class.
• Medicare Part D: Generic EEMT is generally covered, but formulary placement varies by plan. During open enrollment, help patients choose a plan that covers their medications.

Final Thoughts

Helping patients afford Esterified Estrogens/Methyltestosterone doesn't require a lot of extra time — it requires awareness. The biggest wins come from knowing that discount coupons can cut the cash price by 70%, that patient assistance programs exist for those in financial hardship, and that a brief cost conversation at the point of prescribing can prevent a non-fill down the line.

For more clinical resources on this medication, see our provider guides on helping patients find it in stock and navigating shortage situations. And sign up at Medfinder for Providers to give your patients a faster path to finding pharmacies and savings.